Trial site
General Hospital of Eastern Theater Command
- 8running trials
- 8closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Brain aneurysm1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Fabry disease1 trial
- Head and neck cancer1 trial
- IgA nephropathy1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 26 trials
- Phase 35 trials
- Phase 1/22 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- BeiGene3 trials
- Daiichi Sankyo2 trials
- Guangdong Hengrui Pharmaceutical Co., Ltd2 trials
- Pfizer2 trials
- Abivax S.A.1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Not yet recruiting
The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer1 recruiting
- Fabry disease1 recruiting
- Head and neck cancer1 recruiting
Closed trials
Completed
Terminated
Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy
Completed
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Completed
Completed
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026